Pulse Biosciences
PLSE
$7.82
Share price
-2.86%
Change (1 day)
3.71%
Change (1 year)
Categories
Operating Margin for Pulse Biosciences (PLSE)
Operating Margin as of May 2024 (TTM): -3,590.80%
According to Pulse Biosciences 's latest financial reports and stock price the company's current Operating Margin is -3,590.80%. At the end of 2021 the company had an Operating Margin of -4,489.42%.
Operating Margin history for Pulse Biosciences from 2022 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -4,489.42% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 PAVmed
PAVM | -13,857.60% | 285.92% | 🇺🇸 USA |
 Philips PHG | -9.70% | -99.73% | 🇳🇱 Netherlands |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.